Link Between Lemtrada, Mortality More Common Than Previously Reported
Lemtrada, News
Treatment with Lemtrada (alemtuzumab) is associated with the death of patients with relapsing-remitting multiple sclerosis (RRMS) more often than previously reported and appears to be most common during the ... Read more